10x Genomics, Inc. TXG Finite Lived Intangible Assets - Gross
Finite Lived Intangible Assets - Gross at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsGross.
The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s finite lived intangible assets - gross.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 10x Genomics, Inc.'s finite lived intangible assets - gross?
- 10x Genomics, Inc. (TXG) reported finite lived intangible assets - gross of $77.42M in Q1 2026.
- What is the long-term trend for 10x Genomics, Inc.'s finite lived intangible assets - gross?
- Over 2 years (2020 to 2025), 10x Genomics, Inc.'s finite lived intangible assets - gross has grown at a 77.2% compound annual growth rate (CAGR), from $24.64M to $77.42M.
- What does finite lived intangible assets - gross mean?
- This metric tracks the total historical cost of intangible assets that have a defined useful life, such as patents, software licenses, or customer relationships. It excludes assets with indefinite lives like certain trademarks or goodwill. It is a key indicator of the company's investment in intellectual property and intangible competitive advantages.